PhRMA· @PhRMA · X·· 22 天前AI 评分8
AI 导读
Fred患有肺纤维化，状态差时几乎无法在家中走动。 2025年10月，FDA批准了一款突破性疗法。因为Fred住在美国，他很快用上了它，生活质量大幅改善。 美国患者比其他国家的患者提前近3年获得新药。 告诉华盛顿，让美国保持领先。 https://ow.ly/sCG650ZKJxV
正文
Fred has pulmonary fibrosis, and on his bad days, he can barely get around the house.
In October 2025 the FDA approved a breakthrough treatment. Because Fred lives in the U.S., he got it fast, drastically improving his quality of life.
Patients in the U.S. get new medicines nearly 3 years sooner than other countries.
Tell Washington to keep America in the lead.
https://ow.ly/sCG650ZKJxV
来源：PhRMA · x.com